However, the same treatment conditions of hepatoma cells that displayed no modulation of TGF‐β/Smad activation allowed HLF‐T cells to escape from drug‐induced cytotoxicity and to induce cell migration, suggesting different use of active TGF‐β signaling rather than its inactivation. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.